GEMFIBROZIL and RENAL FAILURE

Overview

RENAL FAILURE is the #11 most commonly reported adverse reaction for GEMFIBROZIL, manufactured by Parke-Davis Div of Pfizer Inc. There are 559 FDA adverse event reports linking GEMFIBROZIL to RENAL FAILURE. This represents approximately 1.8% of all 30,260 adverse event reports for this drug.

Patients taking GEMFIBROZIL who experience renal failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RENAL FAILURE is a less commonly reported adverse event for GEMFIBROZIL, but still significant enough to appear in the safety profile.

Other Side Effects of GEMFIBROZIL

In addition to renal failure, the following adverse reactions have been reported for GEMFIBROZIL:

• NAUSEA — 883 reports
• FATIGUE — 824 reports
• DRUG INEFFECTIVE — 766 reports
• DIARRHOEA — 725 reports
• PAIN — 692 reports
• DIZZINESS — 617 reports
• RHABDOMYOLYSIS — 604 reports
• DYSPNOEA — 598 reports
• ASTHENIA — 597 reports
• HEADACHE — 561 reports

Other Drugs Associated with RENAL FAILURE

The following drugs have also been linked to renal failure in FDA adverse event reports:

Does GEMFIBROZIL cause RENAL FAILURE?

RENAL FAILURE has been reported as an adverse event in 559 FDA reports for GEMFIBROZIL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RENAL FAILURE with GEMFIBROZIL?

RENAL FAILURE accounts for approximately 1.8% of all adverse event reports for GEMFIBROZIL, making it a notable side effect.

What should I do if I experience RENAL FAILURE while taking GEMFIBROZIL?

If you experience renal failure while taking GEMFIBROZIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages